3 Night Clinic Stay
Check In
Day -1
Check Out
Day 3
You are reading:
Patient Study
|
The PKD Study
Patient Study
The PKD Study
Start date
Various
Renumeration
$4,773
3 nights, 7 appointments
Help Test a New Treatment for Kidney Disease
This clinical study is evaluating a new treatment for PKD1 mutation-associated autosomal dominant polycystic kidney disease (ADPKD), a condition that results in kidney failure. The primary goal is to assess the safety and tolerability of the treatment in adults with confirmed PKD1 mutation-associated ADPKD.
Schedule Example
Cohort 3
7
appointment
Day 14, Day 28, Day 42, Day 56, Day 70, Day 84, Day 168
To Qualify, You Must
Age
Be 18 to 60 years old
Gender
Male or female
Physical Condition
Diagnosed with PKD1 mutation-associated ADPKD
Requirements
Have a BMI between 18 and 32kg/m2
Renumeration
$4,773
Help Test a New Treatment for Kidney Disease
Spots are limited. Find out if you qualify today!
Close
Not sure yet? Keep me updated on paid clinical trials at Linear
Get notified about the latest trials each month and find one that fits your interests and schedule.
"*" indicates required fields